Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Operating Income Loss of $25.16 million for the year ending 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -88.9% in Operating Income Loss from 2024 to 2025.
- This data is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s annual report (Form 10-K), filed with the SEC on February 18, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $39.71 million | Q2 2014: $51.03 million | Q3 2014: $46.17 million | Q4 2014: $40.77 million | Q1 2015: $43.01 million | Q2 2015: $55.74 million | Q3 2015: $55.44 million | Q4 2015: $52.27 million | Q1 2016: $51.47 million | Q2 2016: $58.06 million | Q3 2016: $58.80 million | Q4 2016: $69.09 million | Q1 2017: $69.71 million | Q2 2017: $81.69 million | Q3 2017: $74.06 million | Q4 2017: $62.83 million | Q1 2018: $67.83 million | Q2 2018: $76.71 million | Q3 2018: $84.36 million | Q4 2018: $102.48 million | Q1 2019: $69.79 million | Q2 2019: $79.77 million | Q3 2019: $92.80 million | Q4 2019: $108.79 million | Q1 2020: $94.28 million | Q2 2020: $76.77 million | Q3 2020: $132.75 million | Q4 2020: $128.93 million | Q1 2021: $123.70 million | Q2 2021: $137.55 million | Q3 2021: $155.80 million | Q1 2022: $148.78 million | Q2 2022: $187.41 million | Q3 2022: $150.98 million | Q1 2023: $167.89 million | Q2 2023: $164.95 million | Q3 2023: $151.50 million | Q1 2024: $125.98 million | Q2 2024: $151.65 million | Q3 2024: $117.41 million | Q1 2025: $74.67 million | Q2 2025: $100.13 million | Q3 2025: $133.80 million.
- Over the full 18 years of available data (2008 to 2025), CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s Operating Income Loss has grown by 105.6%.
- Historical annual values: Fiscal year 2025: $25.16 million | Fiscal year 2024: $227.35 million | Fiscal year 2023: $617.26 million | Fiscal year 2022: $650.98 million | Fiscal year 2021: $589.86 million | Fiscal year 2020: $432.73 million | Fiscal year 2019: $351.15 million | Fiscal year 2018: $331.38 million | Fiscal year 2017: $288.28 million | Fiscal year 2016: $237.55 million | Fiscal year 2015: $206.45 million | Fiscal year 2014: $177.67 million | Fiscal year 2013: $151.40 million | Fiscal year 2012: $165.77 million | Fiscal year 2011: $174.31 million | Fiscal year 2010: -$298.51 million | Fiscal year 2009: $169.61 million | Fiscal year 2008: -$451.84 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: